GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » K Pharma Inc (TSE:4896) » Definitions » Other Current Payables

K Pharma (TSE:4896) Other Current Payables : 円1 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is K Pharma Other Current Payables?

K Pharma's Other Current Payables for the quarter that ended in Mar. 2024 was 円1 Mil.

K Pharma's quarterly Other Current Payables increased from Sep. 2023 (円0 Mil) to Dec. 2023 (円7 Mil) but then declined from Dec. 2023 (円7 Mil) to Mar. 2024 (円1 Mil).

K Pharma's annual Other Current Payables increased from Dec. 2021 (円-0 Mil) to Dec. 2022 (円0 Mil) and increased from Dec. 2022 (円0 Mil) to Dec. 2023 (円7 Mil).


K Pharma Other Current Payables Historical Data

The historical data trend for K Pharma's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

K Pharma Other Current Payables Chart

K Pharma Annual Data
Trend Dec21 Dec22 Dec23
Other Current Payables
- - 7.27

K Pharma Quarterly Data
Dec21 Dec22 Jun23 Sep23 Dec23 Mar24
Other Current Payables Get a 7-Day Free Trial - - - 7.27 1.12

K Pharma Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


K Pharma Other Current Payables Related Terms

Thank you for viewing the detailed overview of K Pharma's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


K Pharma (TSE:4896) Business Description

Traded in Other Exchanges
N/A
Address
7-7-7 Roppongi, Minato-ku, Tokyo, JPN, 106-0032
K Pharma Inc is a company involved in Research, development, manufacturing, sales and marketing of pharmaceutical products and regenerative medicine products. It is involved in studying of iPs cells in regnerative medecine to treat neurological conditions such as cerebral infarction and SCI.

K Pharma (TSE:4896) Headlines

No Headlines